Knight Therapeutics | GUD - Trade Creditors

Stock Price
7.65
Daily Change
-0.04 -0.52%
Monthly
23.39%
Yearly
36.12%
Q2 Forecast
7.26

Knight Therapeutics reported CAD125.76M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Aurora Cannabis CAD 68.03M 18.68M Dec/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Canopy Growth CAD 19.96M 1.83M Dec/2025
Cronos Group USD 11.64M 775K Dec/2025
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Moderna USD 317M 50M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Organon & Co USD 1.07B 7M Sep/2025
Revvity USD 185.46M 9.66M Dec/2025
Tectonic Therapeutic USD 1.09M 392K Dec/2025
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 3.08M 3.45M Dec/2025